| 34.93 Delayed Data As of Apr 22 |  -0.18 / -0.51%Today’s Change | 27.91 Today|||52-Week Range 41.00 | -1.16% Year-to-Date |
| Can Boston Scientific's (BSX) Steady Growth Aid Q1 Earnings? Apr 18 / Zacks.com - Paid Partner Content | Why J.B. Hunt, Bank of America, and Boston Scientific Slumped Today Apr 16 / MotleyFool.com - Paid Partner Content |
| Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's ... Apr 17 / Zacks.com - Paid Partner Content |
| Previous close | 35.11 |
| Today’s open | 34.90 |
| Day’s range | 34.63 - 35.42 |
| Volume | 7,824,238 |
| Average volume (3 months) | 7,513,117 |
| Market cap | $48.8B |
| Earnings growth (last year) | +1,412.50% |
| Earnings growth (this year) | +6.47% |
| Earnings growth (next 5 years) | +10.40% |
| Revenue growth (last year) | +8.57% |
| P/E ratio | 29.4 |
| Price/Sales | 5.04 |
| Price/Book | 5.57 |
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | -2.85 | -1.25% |
| ZBHZimmer Biomet Holdin... | +1.20 | +1.00% |
| TFXTeleflex Inc | -2.51 | -0.91% |
| ABMDAbiomed Inc | +4.37 | +1.70% |
| Next reporting date | April 24, 2019 |
| EPS forecast (this quarter) | $0.36 |
| Annual revenue (last year) | $9.8B |
| Annual profit (last year) | $1.7B |
| Net profit margin | 17.01% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael F. Mahoney |
Executive Vice President- Operations Edward Mackey |
Corporate headquarters Marlborough, Massachusetts |
